Real-time assessment of critical quality attributes of a continuous granulation process

Pharmaceutical Development and Technology

Volumn 18, Issue 1, 2013, Pages 85-97

  Fonteyne, Margot ^a   Vercruysse, Jurgen ^a   Díaz, Damián Córdoba ^b   Gildemyn, Delphine ^a   Vervaet, Chris ^a   Remon, Jean Paul ^a   Beer, Thomas De ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Continuous granulation; NIR Spectroscopy; Particle size analysis; PAT; Raman Spectroscopy

Indexed keywords

EXCIPIENT; LACTOSE; THEOPHYLLINE;

ARTICLE; DRUG DOSAGE FORM; DRUG GRANULATION; DRUG GRANULE; DRUG MANUFACTURE; DRUG QUALITY; DRUG SOLUBILITY; NEAR INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; QUALITY CONTROL; RAMAN SPECTROMETRY; TABLET COMPRESSION; TEMPERATURE; WATER CONTENT;

EID: 84870895675     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.627869     Document Type: Article

References (33)

1. Leuenberger H. New trends in the production of pharmaceutical granules: Batch versus continuous processing. Eur J Pharm Biopharm 2001;52:289-296. (Pubitemid 33033182)
2. Levin, M. (2001). Introduction, in pharmaceutical process scale-up. New York: Marcel Dekker: P. vii-x.
3. Leuenberger, H., Scale-up in the 4th dimension in the field of granulation and drying or how to avoid classical scale-up. Powder Technol, 2003. 130: P. 225-230. (Pubitemid 36293196)
4. FDA-Adminstration. Guidance for Industry - PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. 2004; Available from: Http://www.fda.gov/ downloads/Drugs/ GuidanceComplianceRegulatoryInformation/ Guidances/ucm070305.pdf
5. Guidance for Industry - Process Validation: General Principles and Practices - January 2011. 2011; Available from: Http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM070336.pdf
6. International Conference on Harmonisation of Technicl Requirements for Registration of Pharmaceuticals for Human Use. Pharmaceutical Development Q8. 2009 [cited 2011]; Available from: Http://www.ich.org/fileadmin/Public-Web-Site/ ICH-Products/ Guidelines/Quality/Q8-R1/Step4/Q8-R2-Guideline.pdf
7. International Conference on Harmonisation of Technical Requirements of Regeistration of Pharmaceuticals for Human Use. Quality Risk Management Q9. 2005 [cited 2011]; Available from: Http://www.ich.org/fileadmin/Public-Web-Site/ICH- Products/ Guidelines/Quality/Q9/Step4/Q9-Guideline.pdf
8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Pharmaceutical Quality System Q10. 2008 [cited 2011]; Available from: Http://www.ich.org/fileadmin/Public-Web- Site/ICH-Products/ Guidelines/Quality/Q10/Step4/Q10-Guideline.pdf
9. Naelapää K, Veski P, Kristensen HG, Rantanen J, Bertelsen P. Building quality into a coating process. Pharm Dev Technol 2010;15:35-45.
10. Gamlen, MJ and Eardley C., Continuous extrusion using a baker perkins mp50 (multipurpose) extruder. Drug Dev Ind Pharm, 1986. 12:1701-1713. (Pubitemid 17178841)
11. Lindberg, NO, Tufvesson C., and Olbjer L. Extrusion of an effervescent granulation with a twin screw extruder, baker perkins mpf 50-D. Drug DevIndPharm, 1987. 13: 1891-1913.
12. Werani, J., et al., Semicontinuous granulation - The process of choice for the production of pharmaceutical granules? Powder Technol, 2004. 140: 163-168. (Pubitemid 38608996)
13. Betz G, Junker-Bürgin P, Leuenberger H. Batch and continuous processing in the production of pharmaceutical granules. Pharm Dev Technol 2003;8:289-297. (Pubitemid 36900235)
14. Vervaet, C., and Remon JP. Continuous Granulation, in Handbook of Pharmaceutical Granulation Technology, Parikh DM., Editor 2009, New York: Informa Healthcare. p. 308-322.
15. Vervaet, C., and Remon JP. Continuous granulation in the pharmaceutical industry. Chemical Engineering Science, 2005. 60: 3949-3957. (Pubitemid 40665423)
16. Keleb EI, Vermeire A, Vervaet C, Remon JP. Continuous twin screw extrusion for the wet granulation of lactose. Int J Pharm 2002;239:69-80. (Pubitemid 34615796)
17. Keleb EI, Vermeire A, Vervaet C, Remon JP. Twin screw granulation as a simple and efficient tool for continuous wet granulation. Int J Pharm 2004;273:183-194. (Pubitemid 38317051)
18. Van Melkebeke B, Vervaet C, Remon JP. Validation of a continuous granulation process using a twin-Screw extruder. Int J Pharm 2008;356:224-230.
19. Djuric D, Van Melkebeke B, Kleinebudde P, Remon JP, Vervaet C. Comparison of two twin-Screw extruders for continuous granulation. Eur J Pharm Biopharm 2009;71:155-160.
20. Aulton, ME and Banks, M. Fluidised bed granulation - factors inuencing the quality of the product. Int J Pharm Technol Prod Manuf, 1981. 2: 24-29.
21. Kristensen, HG and Schaefer T. Granulation - A review of pharmaceutical wet-granulation. Drug Dev Ind Phar, 1987. 13: 803-872.
22. Eriksson, L., et al., Design of Experiments - Principles and Applications 2008, Umea: Umetrics
23. Suzuki, E., Shimomura K., and Sekiguchi K. Thermochemical study of theophylline and its hydrate. Chem Pharmaceut Bull, 1989. 37: P. 493-497. (Pubitemid 19082598)
24. Heinz A, Strachan CJ, Gordon KC, Rades T. Analysis of solid-State transformations of pharmaceutical compounds using vibrational spectroscopy. J Pharm Pharmacol 2009;61:971-988.
25. Bauer J, Spanton S, Henry R, Quick J, Dziki W, Porter W et al. Ritonavir: An extraordinary example of conformational polymorphism. Pharm Res 2001;18:859-866. (Pubitemid 32783524)
26. Airaksinen S, Luukkonen P, Jørgensen A, Karjalainen M, Rantanen J, Yliruusi J. Effects of excipients on hydrate formation in wet masses containing theophylline. J Pharm Sci 2003;92:516-528. (Pubitemid 36258966)
27. Wikström H, Marsac PJ, Taylor LS. In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. J Pharm Sci 2005;94:209-219. (Pubitemid 40116384)
28. Burggraeve A, Van Den Kerkhof T, Hellings M, Remon JP, Vervaet C, De Beer T. Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation. Eur J Pharm Biopharm 2010;76:138-146.
29. Jørgensen A, Rantanen J, Karjalainen M, Khriachtchev L, Räsänen E, Yliruusi J. Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis. Pharm Res 2002;19:1285-1291.
30. Ticehurst MD, Storey RA, Watt C. Application of slurry bridging experiments at controlled water activities to predict the solidstate conversion between anhydrous and hydrated forms using theophylline as a model drug. Int J Pharm 2002;247:1-10. (Pubitemid 35341134)
31. Yoshihashi, Y., et al., Determination of heat of hydration and hydration kinetics of theophylline by thermal analysis. Chem Pharmaceut Bull, 1998;46:1148-1152. (Pubitemid 28371473)
32. Zhang GG, Law D, Schmitt EA, Qiu Y. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv Drug Deliv Rev 2004;56:371-390. (Pubitemid 38202329)
33. Ali HR, Edwards HG, Scowen IJ. Noninvasive in situ identification and band assignments of some pharmaceutical excipients inside USP vials with FT-near-infrared spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc 2009;72:890-896.